Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 20.56% ano a ano.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 1.52B.
Subavaliada
O PE mais recente da empresa é 30.26, em uma faixa percentil baixa de 3 anos.
Compra Institucional
As participações institucionais mais recentes são de 69.61M ações, um aumento de 5.73% em relação ao trimestre anterior.
Mantido por Lee Ainslie
O Super Investidor Lee Ainslie possui 787.27K ações desta empresa.